Verition Fund Management LLC Uro Gen Pharma Ltd. Transaction History
Verition Fund Management LLC
- $23.6 Billion
- Q4 2024
A detailed history of Verition Fund Management LLC transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Verition Fund Management LLC holds 28,672 shares of URGN stock, worth $302,202. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,672
Previous 13,254
116.33%
Holding current value
$302,202
Previous $168,000
81.55%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding URGN
# of Institutions
138Shares Held
39.1MCall Options Held
9.8KPut Options Held
49.2K-
Rtw Investments, LP New York, NY3.83MShares$40.4 Million0.67% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA2.93MShares$30.9 Million0.06% of portfolio
-
Menora Mivtachim Holdings Ltd.2.3MShares$24.3 Million0.15% of portfolio
-
Black Rock Inc. New York, NY2.19MShares$23.1 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.18MShares$23 Million0.0% of portfolio
About UroGen Pharma Ltd.
- Ticker URGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,740,500
- Market Cap $240M
- Description
- UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...